ARTIFICIAL BONE MARKET ANALYSIS

Artificial Bone Market, By Material (Ceramics, Composite, Polymer, Hydroxyapatite, Others), By Application (Spinal Fusion, Dental, Craniomaxillofacial, Joint Reconstruction, Trauma and Extremities), By End User (Hospitals, Specialty Clinics, Research and Academic Institutes ), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Sep 2023
Code : CMI1899
Pages :180
Formats :
Excel and PDF
Industry : Pharmaceutical

Market News

Global Artificial Bone Market: Key Developments

On June 6, 2023, Biocomposites announced the acquisition of ARTOSS GmbH, a specialist manufacturer of bone graft substitutes for use in orthopaedics, spine, foot and ankle, and dentistry. ARTOSS GmbH, will offer its NanoBone technology, along with other products like SBX Putty, to Biocomposites global distribution network, allowing them to reach surgeons and patients in over 40 countries.

In November 2020, OssDsign AB announced the signing of an agreement to acquire the privately held Scottish bone graft specialist company Sirakoss Ltd. The acquisition broadens OssDsign AB’s product portfolio with the 510(k)-cleared Osteo3 ZP Putty, a next-generation synthetic bone graft substitute for use in orthopaedic surgery.

In January 2020, Halma plc, a technology company, announced the acquisition of NovaBone Products, LLC, a designer and manufacturer of US FDA-approved synthetic bone graft products.

On January 20, 2023, Nobel Biocare, a provider of dental implant systems, in partnership with Mimetis Biomaterials S.L., a biomedical company, announced the launch of Creos Syntogain, a biomimetic bone graft substitute.